| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 8.3e-05 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.00019 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.0045 | 1 |